Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 4, 1995 - Issue 4
Submit an article Journal homepage
37
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Section Review—Central & Peripheral Nervous Systems: Pre-Clinical Pharmacology of New Atypical Antipsychotics in Late Stage Development

Jeffrey M Goldstein ZENECA Pharmaceuticals, 1800 Concord Pike, Wilmington, DE, 19897, USA
Pages 291-298 | Published online: 03 Mar 2008

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Monsheel S Sodhi & Robin M Murray. (1997) Future therapies for schizophrenia. Expert Opinion on Therapeutic Patents 7:2, pages 151-165.
Read now
Phil Meats. (1997) Quetiapine (‘Seroquel’); an effective and well-tolerated atypical antipsychotic. International Journal of Psychiatry in Clinical Practice 1:4, pages 231-239.
Read now
Jill GC Rasmussen. (1997) Drug treatments for schizophrenia — past, present and future. International Journal of Psychiatry in Clinical Practice 1:4, pages 227-230.
Read now
Richard L. Borison. (1997) Recent Advances in the Pharmacotherapy of Schizophrenia. Harvard Review of Psychiatry 4:5, pages 255-271.
Read now

Articles from other publishers (23)

Wen-Tao Wang, Hao Qian, Jian-Wei Wu, Xiao-Wen Chen & Jian-Qi Li. (2019) Synthesis and antidepressant-like activity of novel alkoxy-piperidine derivatives targeting SSRI/5-HT1A/5-HT7. Bioorganic & Medicinal Chemistry Letters 29:24, pages 126769.
Crossref
Georg Nikisch, Pierre Baumann, Bernhard Kie?ling, Michael Reinert, Georg Wiedemann, Jan Kehr, Aleksander A. Math?Markus Piel, Frank Roesch, Heike Weisser, Peter Schneider & Andreas Hertel. (2010) RETRACTED: Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine. Journal of Psychiatric Research 44:12, pages 754-759.
Crossref
B. Ravi Shankar. (2007) Quetiapine-Induced Leucopenia and Thrombocytopenia. Psychosomatics 48:6, pages 530-531.
Crossref
Hugh M. Jones, Michael J. Brammer, Mary O’Toole, Tess Taylor, Ruth I. Ohlsen, Richard G. Brown, Richard Purvis, Steven Williams & Lyn S. Pilowsky. (2004) Cortical effects of quetiapine in first-episode schizophrenia: A preliminary functional magnetic resonance imaging study. Biological Psychiatry 56:12, pages 938-942.
Crossref
George E Jaskiw, Per T Thyrum, Matthew A Fuller, Lisa A Arvanitis & Chiao Yeh. (2004) Pharmacokinetics of Quetiapine in Elderly Patients with Selected Psychotic Disorders. Clinical Pharmacokinetics 43:14, pages 1025-1035.
Crossref
Steven G. Potkin, Per T. Thyrum, Gustavo Alva, Rimal Bera, Chiao Yeh & Lisa A. Arvanitis. (2002) The Safety and Pharmacokinetics of Quetiapine When Coadministered With Haloperidol, Risperidone, or Thioridazine. Journal of Clinical Psychopharmacology 22:2, pages 121-130.
Crossref
PETER J. WEIDEN, NAVEED IQBAL, ALAN J. MENDELOWITZ, RAJIV TANDON, DAN L. ZIMBROFF & RUTH ROSS. (2002) Best Clinical Practice with Ziprasidone: Update After One Year of Experience. Journal of Psychiatric Practice 8:2, pages 81-97.
Crossref
Nishan S. Gunasekara, Caroline M. Spencer & Gillian M. Keating. (2002) Spotlight on Ziprasidone in Schizophrenia and Schizoaffective Disorder*. CNS Drugs 16:9, pages 645-652.
Crossref
Henricus G. Ruhé, Hiske E. Becker, Pytha Jessurun, Chris H. Marees, Marten Heeringa & Hans D. B. Vermeulen. (2008) Agranulocytosis and granulocytopenia associated with quetiapine. Acta Psychiatrica Scandinavica 104:4, pages 311-314.
Crossref
Henricus G. Ruhe, Hiske E. Becker, Pytha Jessurun, Chris H. Marees, Marten Heeringa & Hans D. B. Vermeulen. (2001) Agranulocytosis and granulocytopenia associated with quetiapine. Acta Psychiatrica Scandinavica 104:4, pages 311-314.
Crossref
Jaydip Sarkar, Neil Jones & Gary Sullivan. (2016) A case of depersonalization–derealization syndrome during treatment with quetiapine. Journal of Psychopharmacology 15:3, pages 209-211.
Crossref
Paul E. KeckJr.Jr., Karen R. Reeves & Edmund P. Harrigan. (2001) Ziprasidone in the Short-Term Treatment of Patients with Schizoaffective Disorder: Results from Two Double-Blind, Placebo-Controlled, Multicenter Studies. Journal of Clinical Psychopharmacology 21:1, pages 27-35.
Crossref
C. M. E. Stephenson, V. Bigliani, H. M. Jones, R. S. Mulligan, P. D. Acton, D. Visvikis, P. J. Ell, R. W. Kerwin & L. S. Pilowsky. (2018) Striatal and extra-striatal D 2 /D 3 dopamine receptor occupancy by quetiapine in vivo . British Journal of Psychiatry 177:5, pages 408-415.
Crossref
Matteo Balestrieri, Claudio Vampini & Cesario Bellantuono. (2000) Efficacy and safety of novel antipsychotics: a critical review. Human Psychopharmacology: Clinical and Experimental 15:7, pages 499-512.
Crossref
. (2000) Letters to the Editor. The Canadian Journal of Psychiatry 45:7, pages 666-671.
Crossref
Pierre N. Tariot, Carl Salzman, Paul P. Yeung, Joseph Pute & Ihor W. Rak. (2000) Long-term use of quetiapine in elderly patients with psychotic disorders. Clinical Therapeutics 22:9, pages 1068-1084.
Crossref
M.J.A.J.M. Hoes. (2015) Recent antipsychotics in the treatment of psychoses. Acta Neuropsychiatrica 11:3, pages 85-92.
Crossref
Olivier Blin. (2016) A Comparative Review of New Antipsychotics. The Canadian Journal of Psychiatry 44:3, pages 235-244.
Crossref
Lisa A. Arvanitis & Barbara G. Miller. (1997) Multiple fixed doses of ?Seroquel? (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. Biological Psychiatry 42:4, pages 233-246.
Crossref
GR Kuperberg & R Murray. (1996) ADVANCES IN THE TREATMENT OF SCHIZOPHRENIA. International Journal of Clinical Practice 50:6, pages 315-323.
Crossref
Steven R. Hirsch, Christopher G. G. Link, Jeffrey M. Goldstein & Lisa A. Arvanitis. (2018) ICI 204, 636: A New Atypical Antipsychotic Drug. British Journal of Psychiatry 168:S29, pages 45-56.
Crossref
Richard L. Borison, Lisa A. Arvanitis & Barbara G. Milier. (1996) ICI 204,636, an Atypical Antipsychotic. Journal of Clinical Psychopharmacology 16:2, pages 158-169.
Crossref
D. P. van Kammen, J. P. McEvoy, S. D. Targum, D. Kardatzke & T. B. Sebree. (1996) A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. Psychopharmacology 124:1-2, pages 168-175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.